Cardiomyopathy/Myocarditis
RSSArticles
-
Is Less More? Transfemoral TAVR: The Minimalist Approach
Since its initial FDA approval in November 2011, transcatheter aortic valve replacement (TAVR) has rapidly gained acceptance as a standard therapy in the United States. -
Predicting Sudden Death Risk in Hypertrophic Cardiomyopathy
-
Renin-angiotensin System Antagonists in Stable CAD
-
Prehospital Ticagrelor Administration in STEMI Patients Falls Short
-
Is There a Role for Routine Procainamide Infusion in the Evaluation of Patients with Cardiac Arrest?
-
Peri-procedural Management of New Oral Anticoagulants
-
FFR in Stable Coronary Artery Disease: A Second Chance at FAME?
-
PCI vs. CABG in High-Risk Patients
-
False-Positive Exercise Echoes
-
Optimal Pacing Site for Resynchronization Therapy In Heart Failure Patients